FDA Breakthrough Designations Can Knock Off Three Years of Development, Study Finds

Drug Industry Daily
A A
Admission to the FDA’s expedited programs can shave years off clinical development times, according to a new analysis.

To View This Article:

Login

Subscribe To Drug Industry Daily